IHE Publications

Primary Care Low Back Exam factsheet - 2006.  Extracted from the Chronic Pain Management Binder November 2005.  Link to Alberta Ambassador Guideline Adaptation Program

À titre de président du jury, le Dr Alain Lesage, M.D., FRCPC, M.Phil., DFAPA, professeur au département de psychiatrie de l'Université de Montréal et clinicien à l’Institut universitaire en santé mentale de Montréal, Québec, a dirigé un comité spécial dont le mandat était d'élaborer…

This consensus development conference was commissioned by the Government of Alberta to improve the transition of its system of care for people with severe and persistent mental illness (SPMI) toward the community. The system, previously hospital- and institution-centred, is moving towards becoming a community-centred, patient- and family-led one. The development and deployment…

  INTRODUCTION: The objective of this study was to determine the short-term cost impact thatmedical tourism for bariatric surgery has on a public healthcare system. Due to long wait times for bariatric surgery services, Canadians are venturing to private clinics in other provinces/countries. Postoperative care in this population not only burdens the provincial health system…

In November 2014, the Institute of Health Economics partnered with Eli Lilly Canada Inc. and the Canadian Institutes of Health Research’s Institute for Health Services and Policy Research to hold a roundtable to discuss the federal role in healthcare innovation. The roundtable aimed to examine the existing state of healthcare innovation, its strengths and weaknesses (or gaps),…

Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.

PDF of a PowerPoint Presentation by Dr. Ken Butcher, WMC Health Sciences Centre, University of Alberta. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference In this 45 minute presentation, Dr. Butcher reviewed how to diagnose stroke and discussed the burden of Cardioembolic and Cryptogenic Stroke. He talked about the recent…

PDF of a PowerPoint Presentation by Dr. Thomas Jeerakathil, Associate Professor, University of Alberta; Co-physician lead, ASPIRE TIA Triaging Project, Northern Stroke Lead CV/S SCN. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference This presentation looked at the diagnosis of likely TIA syndromes and how to identify and…

PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…

This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the continuously advancing field of stroke prevention and care, with a particular focus on the role of primary care. The forum was…

PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…

  Objectives: To estimate the annual health services utilization (HSU) cost per person with FASD by sex and age; the lifetime HSU cost per person with FASD by sex, and the annual HSU cost of FASD for Alberta by sex.

The purpose of this roundtable was to gather a small, select group of thought leaders to engage in informed discourse, which was summarized in a report submitted to the new federal Healthcare Innovation Advisory Panel. This roundtable, created in response to the Federal Healthcare Innovation Advisory Panel’s call for stakeholder input, was an exciting opportunity to…

  BACKGROUND & AIMS: Infliximab is effective for induction and maintenance of response in patients with moderate to moderately severe ulcerative colitis. Previous cost analyses of infliximab treatment for ulcerative colitis used models of colectomy vs infliximab and response rates derived from early clinical trials. In real life, therapeutic options are more complex; patients…

PDF of a PowerPoint presentation by Dr. Jitender Sareen, MD, FRCPC. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Mr. David McDaid, BSC, MSc, MSc. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Heinz Katschnig, MD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Elliot Goldner, MD, FRC(P), MHSc. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Antonio Lora, MD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Luis Salvador-Carulla, MD, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Eric Latimer, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Carol Adair, MSc, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Mr. Steve Lurie, BA, MSW, MM. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Giovanni de Girolamo, MD, PhD. Consensus Development Conference on Improving Mental Health Transitions

The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS) hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 - 6, 2014.

PDF of a PowerPoint presentation by Mr. Orrin Lyseng. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Linda Gask, MSc, PhD, FRCPsych, FRCGP. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Dan Cohen, MD, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Richard Warner, MD, DPM. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Mr. Gerrit van der Leer. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Philippa Garety, MA, MPhil, MA (Ed), PhD, FBPsS. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Thomas Becker, Dr. Med. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Thomas Raedler, MD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Mr. Howard Sapers. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Tim Aubry, BA, MA, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Ms. Sara Lapsley, BA, MA (Candidate). Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Scott Patten, MD, FRCPC, PhD. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Oliver Mason, DPhil, DClinPsy. Consensus Development Conference on Improving Mental Health Transitions

PDF of a PowerPoint presentation by Dr. Roger Bland, CM, MB, ChB, FRCPC, FRCPsych. Consensus Development Conference on Improving Mental Health Transitions

Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support Unit (Ontario) and AstraZeneca Canada. It was held in conjunction with the annual Canadian Association for Population Therapeutics (CAPT).…

Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support…

PDF of a PowerPoint presentation by Dr. Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's Hospital. Real World Evidence: Priority Setting for Action Roundtable

PDF of a PowerPoint presentation by Mr. Neil Corner, Director, Innovative Solutions (Real World Evidence Lead) at IMS Brogan. Real World Evidence: Priority Setting for Action Roundtable

  Objectives: To estimate incidence and prevalence of FASD by sex and age in Alberta, Canada.

  Abstract: Canadian and US health systems have often been characterized as having vastly different approaches to the financing and delivery of healthcare, with Canada portrayed as more reliant on rationing based on costs. In this article, we examine the similarities and differences between the two countries, the evolution and current role of health economic evaluation, and…

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the clinical effectiveness and safety of hysteroscopic tubal sterilization, and the value for money associated with adopting hysteroscopic tubal sterilization in Alberta. Section Authors: Section One – Background and Context: Carmen…

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the best available research evidence on the safety and effectiveness, cost effectiveness and budget impact of using Endovenous Laser Ablation (EVLA) or Endovenous Radiofrequency Ablation (RFA) in the management of symptomatic varicose…

  OBJECTIVE: To provide Canadian estimates of health care utilization costs associated withrheumatoid arthritis (RA)-related and non-RA-related care within 4 treatment strategies and in different physical functioning categories.

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the safety, screening accuracy, therapeutic efficacy, patient outcomes and cost effectiveness of first trimester Quad (1T-Quad) +/- NT and NIPT screening for fetal trisomies. Section Authors: Section One – Technology Effectiveness and Safety: Ken Bond,…

  OBJECTIVE: Sustained remission in rheumatoid arthritis (RA) results in healthcare utilizationcost savings. We evaluated the variation in estimates of savings when different definitions ofremission [2011 American College of Rheumatology/European League Against Rheumatism Boolean Definition, Simplified Disease Activity Index (SDAI) ≤ 3.3, Clinical Disease Activity Index…

  BACKGROUND: Interest in the well-being of physicians has increased because of their contributions to the healthcare system quality. There is growing recognition that physicians are exposed to workplace factors that increase the risk of work stress. Long-term exposure to high work stress can result in burnout. Reports from around the world suggest that about one-third to…

Summary of Systematic Reviews, Primary Studies, and Evidence-based Guidelines. The following research questions were addressed in this review: What are the clinical effects of a universal screening strategy for ARO carriage when compared with no screening? What are the clinical effects of a universal screening strategy for ARO carriage when compared with targeted screening (screening…

This discussion paper has been produced in response to a request from CIHR Institute of Health Services and Policy Research (CIHR IHSPR). The discussion paper will provide guidance to those tasked with conducting an economic evaluation of complex health system interventions. The guidance will be an elaboration of existing National guidelines for economic evaluation, and serve as…

Antibiotic-Resistant Organisms (AROs) are a serious health problem, though they are more prevalent in some settings than others. We were asked to make findings and develop recommendations on how to address surveillance of and screening for AROs in acute care hospitals. This consensus statement addresses these requests. However, confining the discussion and recommendations to hospitals…

PDF of a PowerPoint presentation by Dr. Elizabeth Bryce, BSc, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Daniel Gregson, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Lindsay Nicolle, BSc, BSc (med), MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Anthony Harris, MD, MPH. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPath. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Ms. Kim Neudorf. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Yves Longtin, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Trish Perl, MD, MSc. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Eli Perencevich, MD, MS. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Mark Loeb, BSc, MSc, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Serge Desnoyers, PhD. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Pilar Ramon-Pardo, MD, PhD. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Howard Njoo, MD, MHSc. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Julian Davies, BSc, PhD, FRS. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Scott McEwen, DVM, DVSc, Dip ACVP. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Joel Kettner, MD, MSc, FRCSC, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Andrew Simor, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Robert Weinstein, MD. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. James Talbot, PhD, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. David Patrick, MD, FRCPC, MHSc. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Michael Edmond, MD, MPH, MPA. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Henri Verbrugh, MD, PhD, FIDSA. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Allison McGeer, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. Susan Huang, MD, MPH. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

PDF of a PowerPoint presentation by Dr. John Jernigan, MD, MS. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)

The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 - 20, 2014, was the first event of its kind to look at issues in the field of AROs.

  BACKGROUND: Interest in the impact of burnout on physicians has been growing because of the possible burden this may have on health care systems. The objective of this study is toestimate the cost of burnout on early retirement and reduction in clinical hours of practicingphysicians in Canada.

The objective of this paper is to estimate the additional costs to the criminal justice system associated with people with mental illness who go through the system. The focus of the report is on costs in Alberta.

Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the potential role of low dose computed tomography (LDCT) in screening for lung cancer in adults aged 50 years or older in Alberta. Section Authors: Section One – Social and System Demographics Analysis: Bing Guo, Dagmara Chojecki Section Two –…

PDF of PowerPoint Presentation by Dr. Dianne Mosher, Chief, Division of Rheumatology, Department of Medicine, University of Calgary.  Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

PDF of a PowerPoint Presentation by Dr. Liam Martin, Professor, University of Calgary. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

PDF of a PowerPoint Presentation by Ms. Cheryl Koehn, Founder and President, Arthritis Consumer Experts (ACE). Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

PDF of a PowerPoint Presentation by Dr. Micheal Guirguis, Drug Stewardship Pharmacist, Alberta Health Services (AHS). Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

PDF of a PowerPoint Presentation by Ms. Suzanne Lepage, Private Health Plan Strategist.  Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

PDF of a PowerPoint Presentation by Dr. Agnes Klein, Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics at Health Canada, Health Canada. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium Note: Slide 16 of this presentation contains an error…

PDF of a PowerPoint Presentation by Dr. Chander Sehgal, Director, Common Drug Review (CDR) and Optimal Use, Canadian Agency for Drugs and Technologies in Health (CADTH).  Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium

Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care.

Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.

PDF of a PowerPoint presentation by Dr. Sube Banerjee, Brighton and Sussex Medical School. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care

PDF of a PowerPoint presentation by Dr. Duncan Robertson, Seniors Health Strategic Clinical Network, Alberta Health Services. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care

PDF of a PowerPoint presentation by Dr. Carole Estabrooks, University of Alberta. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care

PDF of a PowerPoint presentation by Mrs. Corinne Schalm, Alberta Health. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care

PDF of a PowerPoint presentation by Dr. David C. Grabowski, Harvard Medical School. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care

Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.

This informative PowerPoint is publicly available for use as an introductory resource for justice professionals who are seeking an educational tool to assist in group presentations/training regarding involvement of those with Fetal Alcohol Spectrum Disorder (FASD) in the criminal justice system.

Le PowerPoint informative est publiquement disponible pour une utilisation en tant que ressource d'introduction pour les professionnels de la justice qui cherchent un outil pédagogique pour aider à des présentations de groupe / formation concernant la participation de ceux qui ont des troubles causés par l'alcoolisation fœtale (ETCAF ) dans le…

  Should vitamin B12 tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B12 maintenance therapy for Alberta seniors. OBJECTIVE: The aim of this study was to estimate the cost-savings attainable if all patients aged ≥65 years in Alberta, Canada, currently on…

  OBJECTIVES: The objective of this study was to explore the degree to which databases otherthan MEDLINE contribute studies relevant for inclusion in rapid health technology assessments (HTA).

This report has been produced in response to a request from Alberta Health (AH). The objective was to perform a review of practices of engaging committees composed of lay people or members of the general public at international, national, provincial, and regional levels. The review attempts to address the following questions: What scientific evidence is available about committees…

  The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals.  The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…

  BACKGROUND: The use of a restrictive formulary, with placement determined through a drug-reimbursement decision-making process, is one approach to managing drug expenditures.

IHE In Your Pocket 2014 – a handbook of health economic statistics includes the most currently available data, presented in separate sections on the economic burden of illness, health care resources, health behaviours, health status and demographics, and health system performance. IHE In Your Pocket was designed to provide a compact, comprehensive, and comparative overview…